{"organizations": [], "uuid": "6e6573f1199fcef8b2cc232200e55c49b201842f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-mallinckrodt-will-sell-recothrom-p/brief-mallinckrodt-will-sell-recothrom-preveleak-to-baxter-for-185-mln-idUSFWN1P30PG", "country": "US", "domain_rank": 408, "title": "BRIEF-Mallinckrodt Will Sell Recothrom, Preveleak To Baxter for $185 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-08T14:51:00.000+02:00", "replies_count": 0, "uuid": "6e6573f1199fcef8b2cc232200e55c49b201842f"}, "author": "", "url": "https://www.reuters.com/article/brief-mallinckrodt-will-sell-recothrom-p/brief-mallinckrodt-will-sell-recothrom-preveleak-to-baxter-for-185-mln-idUSFWN1P30PG", "ord_in_thread": 0, "title": "BRIEF-Mallinckrodt Will Sell Recothrom, Preveleak To Baxter for $185 Mln", "locations": [], "entities": {"persons": [{"name": "prevelea", "sentiment": "negative"}, {"name": "baxter", "sentiment": "none"}], "locations": [], "organizations": [{"name": "mln reuters staff", "sentiment": "none"}, {"name": "mallinckrodt plc", "sentiment": "none"}, {"name": "mallinckrodt", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "mallinckrodt plc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 8, 2018 / 12:53 PM / Updated 11 minutes ago BRIEF-Mallinckrodt Will Sell Recothrom, Preveleak To Baxter for $185 Mln Reuters Staff \nJan 8 (Reuters) - Mallinckrodt Plc \n* MALLINCKRODT WILL SELL RECOTHROM® AND PREVELEAK® TO BAXTER \n* MALLINCKRODT - TOTAL DEAL CONSIDERATION OF $185 MILLION, WITH $153 MILLION UPFRONT, INCLUDING EXISTING INVENTORY, REMAINDER IN POTENTIAL MILESTONE PAYMENTS \n* MALLINCKRODT PLC - WILL RETAIN RAPLIXA FOR TOPICAL USE AND IS EVALUATING STRATEGIC OPTIONS FOR THIS PRODUCT \n* MALLINCKRODT - ‍ SALE IS ANTICIPATED TO DILUTE CO‘S ADJUSTED EARNINGS PER SHARE BY $0.10 TO $0.15 IN 2018, WHICH WILL BE OFFSET BY SHARES REPURCHASED DURING Q4 2017​ \n* MALLINCKRODT PLC - COMPANY WILL DISCONTINUE MARKETING OF RAPLIXA UPON CLOSE OF BAXTER TRANSACTION \n* MALLINCKRODT PLC - PROCEEDS FROM SALE WILL BE USED BY COMPANY TOWARD PAYING DOWN DEBT \n* MALLINCKRODT PLC - ‍WRITE-OFF FOR RAPLIXA​ WILL BE REPORTED FOR Q4 2017 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-08T14:51:00.000+02:00", "crawled": "2018-01-08T15:12:01.007+02:00", "highlightTitle": ""}